Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
1076
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $8.49M | 0.02% |
765,665
+21,128
| +3% | +$272K |
|
1077
BHP
BHP
$249B
| $8.48M | 0.02% |
233,542
+90,891
| +64% | +$3.67M |
|
|
ACRE
1078
Ares Commercial Real Estate
ACRE
$262M
| $8.48M | 0.02% |
744,167
+112,785
| +18% | +$1.3M |
|
|
ELOS
1079
DELISTED
Syneron Medical Ltd
ELOS
| $8.47M | 0.02% |
797,431
+36,282
| +5% | +$425K |
|
|
ASNA
1080
DELISTED
Ascena Retail Group, Inc.
ASNA
| $8.46M | 0.02% |
+25,402
| New | +$7.77M |
|
|
NUAN
1081
DELISTED
Nuance Communications, Inc.
NUAN
| $8.43M | 0.02% |
556,048
-10,423
| -2% | -$147K |
|
1082
Quad
QUAD
$516M
| $8.42M | 0.02% |
455,107
-27,026
| -6% | -$569K |
|
|
CNCE
1083
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $8.41M | 0.02% |
564,810
+192,988
| +52% | +$2.94M |
|
|
RVNC
1084
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.4M | 0.02% |
262,609
+242,719
| +1,220% | +$6.24M |
|
1085
Live Nation Entertainment
LYV
$43.3B
| $8.4M | 0.02% |
305,468
+79,477
| +35% | +$2.17M |
|
1086
SLM Corp
SLM
$4.97B
| $8.36M | 0.02% |
847,453
+825,329
| +3,730% | +$8.35M |
|
|
LADR
1087
Ladder Capital
LADR
$1.26B
| $8.36M | 0.02% |
600,639
+511,989
| +578% | +$7.35M |
|
1088
Option Care Health
OPCH
$3.46B
| $8.36M | 0.02% |
575,584
+95,004
| +20% | +$1.61M |
|
|
EVHC
1089
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $8.36M | 0.02% |
70,699
-67,299
| -49% | -$7.65M |
|
1090
Orthofix Medical
OFIX
$393M
| $8.32M | 0.02% |
251,332
+143,337
| +133% | +$4.93M |
|
|
ENIA
1091
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $8.3M | 0.02% |
972,645
+510,901
| +111% | +$4.71M |
|
1092
Manulife Financial
MFC
$71.3B
| $8.28M | 0.02% |
445,316
+388,127
| +679% | +$7.21M |
|
1093
CALL
Hilton Worldwide
HLT
$74.3B
| $8.27M | 0.02% |
+100,000
| New | +$8.78M |
|
|
PMCS
1094
DELISTED
P M C SIERRA INC
PMCS
| $8.26M | 0.02% |
964,829
+196,275
| +26% | +$1.75M |
|
1095
CALL
Alcoa
AA
$13.4B
| $8.25M | 0.02% |
307,948
+306,200
| +17,517% | +$9.49M |
|
1096
United States Oil Fund
USO
$2B
| $8.25M | 0.02% |
+51,868
| New | +$8.24M |
|
1097
Sumitomo Mitsui Financial
SMFG
$159B
| $8.22M | 0.02% |
+924,769
| New | +$8.03M |
|
|
NTUS
1098
DELISTED
Natus Medical Inc
NTUS
| $8.19M | 0.02% |
192,479
+104,659
| +119% | +$4.17M |
|
|
NSTG
1099
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.17M | 0.02% |
529,975
+81,570
| +18% | +$1.09M |
|
|
PES
1100
DELISTED
Pioneer Energy Services Corp.
PES
| $8.17M | 0.02% |
1,288,704
-999,125
| -44% | -$6.84M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.